Wilms Tumor Ppt New [repack] -
This report provides a structured overview of Wilms tumor (nephroblastoma) based on 2025–2026 clinical guidelines and research. It is designed for use as a detailed reference for a medical presentation. 🧬 Overview & Epidemiology
Most common pediatric renal cancer (95% of childhood kidney cases).
Incidence: Approximately 650 new cases yearly in the U.S.; 1 in 10,000 children globally.
Median Age: 3.5 years; 90% of cases are diagnosed before age 7. wilms tumor ppt new
Laterality: 90% are unilateral; 10% are bilateral or multifocal (suggesting germline mutations). 🩺 Clinical Presentation
Abdominal Mass: Usually painless, firm, smooth, and non-tender (83% of cases). Abdominal Pain: Occurs in ~37% of patients.
Hypertension: Present in 20–25% due to increased renin activity. Hematuria: Microscopic or gross blood in urine (21–25%). Constitutional Symptoms: Fever, anorexia, and vomiting. Genetic Predisposition & Syndromes This report provides a structured overview of Wilms
Approximately 10–15% of cases are associated with a predisposition syndrome. Genetic Marker WAGR Wilms, Aniridia, Genitourinary anomalies, Retardation 11p13 deletion (WT1) Denys-Drash Nephropathy, Wilms, ambiguous genitalia WT1 mutation Beckwith-Wiedemann Overgrowth, macroglossia, omphalocele 11p15 (WT2/IGF2) Perlman Fetal gigantism, nephroblastomatosis 🔬 Pathology & Staging Histology Types
Favorable Histology (FH): Standard triphasic pattern (blastemal, epithelial, stromal cells).
Anaplastic Histology: Presence of enlarged nuclei and hyperchromasia; associated with chemoresistance and poorer prognosis. Staging (COG/NWTS System) How to Create an Effective PowerPoint on Wilms
How to Create an Effective PowerPoint on Wilms Tumor (Nephroblastoma)
A well-designed PowerPoint presentation on Wilms Tumor can simplify a complex pediatric oncology topic. Whether you are preparing for a medical school seminar, a residency teaching round, or a parent education session, the key is balancing pathology, clinical management, and visual clarity. Below is a blueprint for structuring your PPT, along with essential content to include.
Slide 7: Diagnostic Workup
- Imaging:
- Abdominal Ultrasound: First-line test to confirm cystic vs. solid mass and assess IVC/renal vein thrombosis.
- CT Abdomen/Pelvis: Defines extent, contralateral kidney check, and lymph node status.
- Chest CT: Essential for staging lung metastases (Stage IV).
- Labs:
- CBC, LFTs, Renal function (BMP).
- Urinalysis (hematuria).
- Biopsy:
- Controversial: In the US/COG protocols, upfront biopsy is generally avoided (risk of spillage/upstaging) unless tumor is unresectable or bilateral. Diagnosis is confirmed at surgery.
Slide 10: Take-Home Pearls
- Always palpate an abdominal mass gently (rupture risk → upstaging).
- Wilms Tumor is highly chemosensitive – survival is excellent with proper risk stratification.
- Do not biopsy before referral to a pediatric oncology center unless absolutely necessary.
Slide 2: Introduction & Epidemiology
- Definition: Most common primary malignant renal tumor of childhood.
- Origin: Embryonal renal stem cells (metanephric blastema).
- Epidemiology:
- Incidence: ~1 in 10,000 children.
- Peak Age: 3–4 years old (rare in neonates and adults).
- Slight female predominance.
- Key Stat: Accounts for ~6% of all childhood cancers.
Slide 5: Pathology (The "Triphasic" Appearance)
- Gross Appearance: Large, bulky mass; usually solitary; well-circumscribed with a pseudocapsule. Cut surface is fleshy, gray-white, and often necrotic/hemorrhagic.
- Microscopic Features (Triphasic Histology):
- Blastema: Small blue round cells (immature, malignant component).
- Epithelium: Immature glomeruli and tubules.
- Stroma: Fibrocytic or myxoid spindle cells.
- Anaplasia (Critical Concept):
- Defined by large, hyperchromatic nuclei and multipolar mitotic figures.
- Focal Anaplasia: Better prognosis.
- Diffuse Anaplasia: Poor prognosis, resistant to chemotherapy.
Wilms Tumor PPT New: A Modern Guide to Presentation, Diagnosis, and Treatment Updates
Keywords: Wilms tumor ppt new, nephroblastoma slides, pediatric renal cancer, COG protocol, Umbrella protocol, pediatric oncology lecture
Slide 5: Pathology – The 2025 WHO Classification Update
Add this slide to your PPT – crucial for “new”.
The 5th edition (WHO 2022, implemented globally by 2025) introduces:
- Favorable histology – triphasic; excellent prognosis.
- Diffuse anaplasia – large, hyperchromatic nuclei, atypical mitoses; high risk.
- Focal anaplasia – intermediate.
- New entity: Cystic partially differentiated nephroblastoma (benign behavior; no chemo).
- New: Blastemal-predominant subtype after SIOP chemo – poor prognosis regardless of stage → upgrade to high-risk therapy.
Microscopy images in PPT are mandatory here.